MedTrace Logo

A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population

NCT06052319 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 277

Last updated 2025-04-27

No results posted yet for this study

Summary

The purpose of this study is to assess the engagement and usefulness of Care4Today® Connect CAD-PAD digital platform in participants with coronary artery disease or peripheral artery disease (CAD or PAD).

Conditions

  • Coronary Artery Disease (CAD)
  • Peripheral Artery Disease (PAD)

Interventions

DEVICE

Care4Today® Connect CAD-PAD Mobile Application

Participants will not receive any drug intervention in this study. Participants will use Care 4Today® Connect CAD-PAD mobile application for 3 months. The study will assess participant engagement and usefulness.

Sponsors & Collaborators

  • HCA Research Institute, LLC

    collaborator UNKNOWN

  • Janssen Scientific Affairs, LLC

    lead INDUSTRY

Principal Investigators

  • Janssen Scientific Affairs, LLC Clinical Trial · Janssen Scientific Affairs, LLC

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-29
Primary Completion
2024-08-13
Completion
2024-08-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06052319 on ClinicalTrials.gov